Amanda Cray
Investor Relations Contact bij FUSN PHAR
Profiel
Amanda Cray is currently a Senior Director-IR & Corporate Communications at Fusion Pharmaceuticals, Inc. Prior to her current position, she worked as an Associate Director-IR & Corporate Communications at Aegerion Pharmaceuticals, Inc. from 2012 to 2019, and as a Director-IR & Corporate Communications at Novelion Therapeutics, Inc. from 2016 to 2019.
Before that, she worked as a Senior Account Executive at LaVoie Strategic Communications Group, Inc., an Associate at Sharon Merrill Associates, Inc., and an Account Manager at Harron & Associates, Inc. Ms. Cray received a graduate degree from Boston University and an undergraduate degree from the University of New Hampshire.
Actieve functies van Amanda Cray
| Bedrijven | Functie | Begin |
|---|---|---|
| FUSN PHAR | Investor Relations Contact | - |
Eerdere bekende functies van Amanda Cray
| Bedrijven | Functie | Einde |
|---|---|---|
| AEGERION PHARMACEUTICALS, INC. | Investor Relations Contact | 01-07-2019 |
| NOVELION THERAPEUTICS INC. | Investor Relations Contact | 01-07-2019 |
Sharon Merrill Associates, Inc.
 Sharon Merrill Associates, Inc. Miscellaneous Commercial ServicesCommercial Services Sharon Merrill Associates, Inc. is a full-service investor relations and corporate communications strategic advisory agency. Sharon Merrill Associates is based in Boston, MA. The private company has an international reputation as a preeminent strategic IR advisory firm. Sharon Merrill partners with IROs and the C-suite to drive value for both external and internal stakeholders. Clients have relied on their senior-level counsel and communications expertise for more than 35 years to guide them through every challenge and meet every opportunity. The company takes a strategic approach to every situation as they leverage sophisticated stakeholder engagement and innovative digital media, social media, and branding strategies to help clients build enduring and value-creating relationships with the right audiences. Maureen T. Wolff has been the CEO of the company since 1985. | Corporate Officer/Principal | - |
| Harron & Associates, Inc. | Corporate Officer/Principal | - |
LaVoie Strategic Communications Group, Inc.
 LaVoie Strategic Communications Group, Inc. Advertising/Marketing ServicesCommercial Services LaVoie Strategic Communications Group, Inc. provides strategic communications programs, strategy and brand positioning services to the life science and pharmaceutical clients. It offers marketing strategy, investor and public relations, corporate communications, and consulting services. The firm provides program planning, website content development, product launch, investor targeting, corporate positioning, annual reports, and executive counsel consulting services. The company was founded in 2001 by Donna L. LaVoie and is headquartered in Boston, MA. | Corporate Officer/Principal | - |
Opleiding van Amanda Cray
| Boston University | Graduate Degree |
| University of New Hampshire | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| FUSN PHAR | Health Technology |
| Bedrijven in privébezit | 5 |
|---|---|
Aegerion Pharmaceuticals, Inc.
 Aegerion Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Aegerion Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in the development and commercialization of therapies for patients with debilitating rare diseases. The company was founded by David I. Scheer, Gerald L. Wisler and William H. Lewis in 2005 and is headquartered in Cambridge, MA. | Health Technology |
LaVoie Strategic Communications Group, Inc.
LaVoie Strategic Communications Group, Inc. Advertising/Marketing ServicesCommercial Services LaVoie Strategic Communications Group, Inc. provides strategic communications programs, strategy and brand positioning services to the life science and pharmaceutical clients. It offers marketing strategy, investor and public relations, corporate communications, and consulting services. The firm provides program planning, website content development, product launch, investor targeting, corporate positioning, annual reports, and executive counsel consulting services. The company was founded in 2001 by Donna L. LaVoie and is headquartered in Boston, MA. | Commercial Services |
Sharon Merrill Associates, Inc.
Sharon Merrill Associates, Inc. Miscellaneous Commercial ServicesCommercial Services Sharon Merrill Associates, Inc. is a full-service investor relations and corporate communications strategic advisory agency. Sharon Merrill Associates is based in Boston, MA. The private company has an international reputation as a preeminent strategic IR advisory firm. Sharon Merrill partners with IROs and the C-suite to drive value for both external and internal stakeholders. Clients have relied on their senior-level counsel and communications expertise for more than 35 years to guide them through every challenge and meet every opportunity. The company takes a strategic approach to every situation as they leverage sophisticated stakeholder engagement and innovative digital media, social media, and branding strategies to help clients build enduring and value-creating relationships with the right audiences. Maureen T. Wolff has been the CEO of the company since 1985. | Commercial Services |
| Harron & Associates, Inc. | |
Novelion Therapeutics, Inc.
 Novelion Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Novelion Therapeutics, Inc. engaged in the development and commercialization of pharmaceuitical products. It focused in providing new standards of care for individuals living with rare diseases. The company was founded on February 3, 1981 and was headquartered in Vancouver, Canada. | Health Technology |
